NCT07412301

Brief Summary

The association between celiac axis stenosis and morbidity after pancreaticoduodenectomy is the primary focus of the study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for all trials

Timeline
43mo left

Started Nov 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Nov 2024Nov 2029

Study Start

First participant enrolled

November 14, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2029

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

4 years

First QC Date

February 9, 2026

Last Update Submit

February 9, 2026

Conditions

MorbidityCeliac Axis StenosisPancreaticoduodenectomyPancreatic Cancer

Outcome Measures

Primary Outcomes (1)

  • Morbidity

    one month

Study Arms (1)

Without celiac axis stenosis

With celiac axis stenosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pancreatic cancer patients submitted to pancreaticojejunostomy in the University Hospital of Larissa

You may qualify if:

  • Patients over 18 years old
  • Diagnosis of pancreatic cancer
  • Pancreaticoduodenectomy

You may not qualify if:

  • Previous pancreatectomy
  • Non resectable tumors
  • Serious comorbidities
  • Patients lost to follow up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Larissa

Larissa, 41222, Greece

Location

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

February 9, 2026

First Posted

February 17, 2026

Study Start

November 14, 2024

Primary Completion (Estimated)

November 14, 2028

Study Completion (Estimated)

November 14, 2029

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations

GR(1)